Recombinant multi-species RNASEH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNASEH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an endonuclease that specifically degrades the RNA of RNA-DNA hybrids and plays a key role in DNA replication and repair. Alternate in-frame start codon initiation results in the production of alternate isoforms that are directed to the mitochondria or to the nucleus. The production of the mitochondrial isoform is modulated by an upstream open reading frame (uORF). Mutations in this gene have been found in individuals with progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2. Alternative splicing results in additional coding and non-coding transcript variants. Pseudogenes of this gene have been defined on chromosomes 2 and 17. [provided by RefSeq, Jul 2017]
The Alternative Names of target: H1RNA,PEOB2,RNASEH1,RNH1,RNase H1,Ribonuclease H type II,Ribonuclease H1,Rnaseh1

Target products collectionGo to RNASEH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1599-Ag-1/ GM-Tg-hg-SE1599-Ag-2 Human RNASEH1 protein Human
GM-Tg-rg-SE1599-Ag-1/ GM-Tg-rg-SE1599-Ag-2 Rat RNASEH1 protein Rat
GM-Tg-mg-SE1599-Ag-1/ GM-Tg-mg-SE1599-Ag-2 Mouse RNASEH1 protein Mouse
GM-Tg-cynog-SE1599-Ag-1/ GM-Tg-cynog-SE1599-Ag-2 Cynomolgus/Rhesus macaque RNASEH1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1599-Ag-1/ GM-Tg-felg-SE1599-Ag-2 Feline RNASEH1 protein Feline
GM-Tg-cang-SE1599-Ag-1/ GM-Tg-cang-SE1599-Ag-2 Canine RNASEH1 protein Canine
GM-Tg-bovg-SE1599-Ag-1/ GM-Tg-bovg-SE1599-Ag-2 Bovine RNASEH1 protein Bovine
GM-Tg-equg-SE1599-Ag-1/ GM-Tg-equg-SE1599-Ag-2 Equine RNASEH1 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1599-Ag-1/ GM-Tg-hg-SE1599-Ag-2; GM-Tg-rg-SE1599-Ag-1/ GM-Tg-rg-SE1599-Ag-2;
GM-Tg-mg-SE1599-Ag-1/ GM-Tg-mg-SE1599-Ag-2; GM-Tg-cynog-SE1599-Ag-1/ GM-Tg-cynog-SE1599-Ag-2;
GM-Tg-felg-SE1599-Ag-1/ GM-Tg-felg-SE1599-Ag-2; GM-Tg-cang-SE1599-Ag-1/ GM-Tg-cang-SE1599-Ag-2;
GM-Tg-bovg-SE1599-Ag-1/ GM-Tg-bovg-SE1599-Ag-2; GM-Tg-equg-SE1599-Ag-1/ GM-Tg-equg-SE1599-Ag-2
Products Name RNASEH1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNASEH1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNASEH1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.